N- butyloxycarbonyl- methionyl- aspartyl- glycyl- cysteinyl- glutamyl- leucine

inhibits Wnt5a; structure in first source

Also Known As:

Box5 peptide; N-butyloxycarbonyl-Met-Asp-Gly-Cys-Glu-Leu

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 11/17/2009 - "The Box5 peptide directly inhibits Wnt5a signaling, representing an approach to anti-metastatic therapy for otherwise rapidly progressive melanoma, and for other Wnt5a-stimulated invasive cancers."
2.	Melanoma (Melanoma, Malignant) 11/17/2009 - "The Box5 peptide directly inhibits Wnt5a signaling, representing an approach to anti-metastatic therapy for otherwise rapidly progressive melanoma, and for other Wnt5a-stimulated invasive cancers."

1.	Therapeutics